GB1229306A - - Google Patents
Info
- Publication number
- GB1229306A GB1229306A GB3831868A GB1229306DA GB1229306A GB 1229306 A GB1229306 A GB 1229306A GB 3831868 A GB3831868 A GB 3831868A GB 1229306D A GB1229306D A GB 1229306DA GB 1229306 A GB1229306 A GB 1229306A
- Authority
- GB
- United Kingdom
- Prior art keywords
- virus
- iron oxide
- influenza
- aug
- separated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 abstract 8
- 241000700605 Viruses Species 0.000 abstract 6
- 239000000203 mixture Substances 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 206010008631 Cholera Diseases 0.000 abstract 1
- 208000000655 Distemper Diseases 0.000 abstract 1
- 208000000832 Equine Encephalomyelitis Diseases 0.000 abstract 1
- 201000005505 Measles Diseases 0.000 abstract 1
- 208000005647 Mumps Diseases 0.000 abstract 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 abstract 1
- 208000000474 Poliomyelitis Diseases 0.000 abstract 1
- 206010037742 Rabies Diseases 0.000 abstract 1
- 206010046865 Vaccinia virus infection Diseases 0.000 abstract 1
- 208000003152 Yellow Fever Diseases 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 208000014058 canine distemper Diseases 0.000 abstract 1
- 238000010494 dissociation reaction Methods 0.000 abstract 1
- 230000005593 dissociations Effects 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
- 239000002609 medium Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000010805 mumps infectious disease Diseases 0.000 abstract 1
- 201000009240 nasopharyngitis Diseases 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 abstract 1
- 208000007089 vaccinia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3831868 | 1968-08-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1229306A true GB1229306A (enrdf_load_stackoverflow) | 1971-04-21 |
Family
ID=10402685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB3831868A Expired GB1229306A (enrdf_load_stackoverflow) | 1968-08-10 | 1968-08-10 |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB1229306A (enrdf_load_stackoverflow) |
-
1968
- 1968-08-10 GB GB3831868A patent/GB1229306A/en not_active Expired
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lahelle et al. | Hemagglutination with the GDVII strain of mouse encephalomyelitis virus | |
| BR9106374A (pt) | Vacina oral e processo de extrair uma imunoresponsta em um mamifero | |
| ES2052758T3 (es) | Sondas de acidos nucleicos de los virus de papiloma humano. | |
| IE37602B1 (en) | Cyclopentane derivatives | |
| GB1403242A (en) | Aluminium phosphate gel | |
| EP0188262A3 (en) | Process for the isolation of chicken egg white cystatine, antiviral agents containing it and its use as viral protease inhibitor | |
| GB1229306A (enrdf_load_stackoverflow) | ||
| GB1413614A (en) | Virus production | |
| ES2061558T3 (es) | Sondas de hibridacion de acidos nucleicos de papilomavirus humanos y metodos para su empleo. | |
| GB1062703A (en) | Vaccine compositions | |
| GB1375902A (en) | Process for the preparation of unsaturated cycloaliphatic ketones | |
| SE7500130L (enrdf_load_stackoverflow) | ||
| GB1092754A (en) | Blood purification | |
| ES357848A1 (es) | Procedimiento mejorado para la preparacion de una vacuna contra la poliomielitis. | |
| CH554902A (de) | Verfahren zur herstellung der 1:1- und 2:1-additionsverbindungen von phosphanilsaeure an aminoacridine. | |
| CH554789A (de) | Verfahren zur einstellung eines foerderers und schubfoerdereinrichtung zur durchfuehrung des verfahrens. | |
| CH532639A (de) | Verfahren zur Herstellung wasserunlöslicher gelber Monoazofarbstoffe | |
| GB1292197A (en) | Method for the disruption of viruses | |
| SU439956A1 (ru) | Способ получени штаммов вирусов дл стимул ции интерфероногенеза | |
| IT1006032B (it) | Acidi idrossi ed alcossi acetammido triiodobenzoici particolarmente per l impiego come mezzi di contrasto per raggi x | |
| IL28696A (en) | Attenuated live rubella virus vaccine and method of production | |
| SE388203B (sv) | Forfarande for framstellning av vattenlosliga, hartsartade polymerer av en diallylamin eller n-substituerad diallylamin, vilka modifieras med epihalogenhydrin | |
| GB953992A (en) | Vaccine products and method of preparing same | |
| AT318626B (de) | Verfahren zum Herstellen von neuen Thiazolino-pyrimidin-5-onen bzw. von Säureadditionssalzen und optisch aktiven Formen hievon | |
| GB659864A (en) | A method of purifying di-ammonium phosphate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |